Arterra Bioscience Logo

Arterra Bioscience

Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.

ABS | XMIL

Overview

Corporate Details

ISIN(s):
IT0005386369
LEI:
8156006E67B9AB95E292
Country:
Italy
Address:
VIA BENEDETTO BRIN, 69, 80142 NAPOLI
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Arterra Bioscience is a research-based biotechnology company founded in 2004. It specializes in the research, development, and production of innovative, high-value-added active ingredients and sustainable solutions derived from natural sources. The company utilizes proprietary technological platforms, including in vitro bioassays, plant cell cultures, and recombinant protein production, to create its products. Its production focuses on manufacturing stable, preservative-free raw materials through techniques like freeze-drying. Arterra serves a diverse range of industries, including the cosmetics, nutraceuticals, pharmaceuticals, agriculture, food, and medical device sectors. The company's core mission is to identify and develop unique active compounds from natural sources for various industrial applications.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 12:50
Earnings Release
ARTERRA BIOSCIENCE S.P.A.: FATTURATO AL 30 SETTEMBRE 2025 PARI A CIRCA 3,6 MIL…
Italian 280.8 KB
2025-10-02 17:34
Share Issue/Capital Change
ARTERRA BIOSCIENCE COMUNICA LA SOTTOSCRIZIONE DELL’ADDENDUM AL PATTO PARASOCIAL…
Italian 251.2 KB
2025-10-01 11:49
Report Publication Announcement
ARTERRA BIOSCIENCE PARTECIPERÀ ALL’EVENTO “REVERSE ROADSHOW” A NAPOLI
Italian 267.6 KB
2025-09-29 14:00
Earnings Release
Arterra - Il Consiglio di Amministrazione ha approvato la relazione semestrale …
Italian 618.7 KB
2025-09-17 12:01
Major Shareholding Notification
ARTERRA - CAMBIAMENTO SOSTANZIALE IN MATERIA DI ASSETTI PROPRIETARI
Italian 253.5 KB
2025-08-01 17:59
M&A Activity
ARTERRA BIOSCIENCE S.P.A. HA CEDUTO L’INTERA PARTECIPAZIONE DETENUTA NEL CAPITA…
Italian 245.2 KB
2025-07-31 16:27
Regulatory News Service
ARTERRA BIOSCIENCE S.P.A. HA CEDUTO L’INTERA PARTECIPAZIONE DETENUTA NEL CAPITA…
Italian 244.9 KB
2025-07-18 13:28
Earnings Release
ARTERRA BIOSCIENCE S.P.A.: FATTURATO AL 30 GIUGNO 2025 PARI A CIRCA 2,6 MILIONI…
Italian 256.6 KB
2025-06-23 17:43
Director's Dealing
Arterra - Allegato A (Manager) - Notifica di comunicazione
Italian 133.7 KB
2025-06-23 17:36
Major Shareholding Notification
ARTERRA - CAMBIAMENTO SOSTANZIALE IN MATERIA DI ASSETTI PROPRIETARI
Italian 254.7 KB
2025-06-12 21:25
Report Publication Announcement
ARTERRA BIOSCIENCE S.P.A. PARTECIPA ALL’EVENTO “FINANCIAL GALÀ” ORGANIZZATO DA …
Italian 350.6 KB
2025-05-19 19:14
Capital/Financing Update
ARTERRA - FINANZIAMENTO E CONCESSIONE AGEVOLAZIONI PER IL PROGETTO “SmartLAB 2.…
Italian 319.2 KB
2025-05-06 11:21
Earnings Release
ARTERRA - FATTURATO AL 31 MARZO 2025 PARI A CIRCA 1,3 MILIONI DI EURO
Italian 253.5 KB
2025-04-29 13:44
Post-Annual General Meeting Information
ARTERRA BIOSCIENCE - ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Italian 347.4 KB
2025-04-23 18:40
Pre-Annual General Meeting Information
ARTERRA - DEPOSITO E PUBBLICAZIONE DELLE LISTE PER LA NOMINA DEI MEMBRI DEL CON…
Italian 302.5 KB

Automate Your Workflow. Get a real-time feed of all Arterra Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arterra Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arterra Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.